• Publications
  • Influence
The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa.
OBJECTIVE To determine the safety and efficacy of the artificial silicon retina (ASR) microchip implanted in the subretinal space to treat vision loss from retinitis pigmentosa. METHODS The ASRExpand
  • 447
  • 17
  • PDF
Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP.
Uveal melanoma (UM) is the most common cancer in adult eyes. Approximately 80% of UMs harbor somatic activating mutations in GNAQ or GNA11 (encoding Gq or G11, respectively). Herein, we show in bothExpand
  • 275
  • 15
  • PDF
Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
PURPOSE To compare the results of intravitreal bevacizumab (IVB) injection alone or in combination with intravitreal triamcinolone acetonide (IVT) versus macular laser photocoagulation (MPC) as aExpand
  • 218
  • 9
  • PDF
Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)
Aim: To evaluate the effect of topically administered bevacizumab (Avastin) on experimental corneal neovascularisation in rats. Methods: Silver nitrate sticks (75% silver nitrate, 25% potassiumExpand
  • 197
  • 7
Micro- and nanoparticulates.
OBJECTIVES Pharmacotherapeutics has begun to play an increasingly important role in the management of patients with neovascular age-related macular degeneration (AMD). Because micro- andExpand
  • 81
  • 7
A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring.
We describe the surgical excision of submacular scar in end-stage age-related macular degeneration and transplantation of autologous and homologous retinal pigment epithelial (RPE) cells. TheExpand
  • 197
  • 6
Purpose: To evaluate the retinal toxicity of varying doses of bevacizumab when injected intravitreally in rabbits. Bevacizumab has been approved by the US Food and Drug Administration for theExpand
  • 302
  • 5
  • PDF
Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema
Purpose: To determine the safety and efficacy of intravitreal triamcinolone acetonide (TAAC) injections in patients with refractory cystoid macular edema (CME) after cataract extraction. Setting: LSUExpand
  • 171
  • 5
Triamcinolone acetonide in ocular therapeutics.
Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years. Its use has increased dramatically in recent years for periocular and intraocular treatment of retinalExpand
  • 111
  • 5